Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MGAT4B | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | ACTN4 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | C15orf38-AP3S2 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | NHLRC1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | PLK4 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CENPV | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | GNS | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | CEP162 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | RPF2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | EFEMP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |